BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 15274642)

  • 1. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases.
    Marmorstein R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):904-9. PubMed ID: 15506920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.
    Borra MT; Denu JM
    Methods Enzymol; 2004; 376():171-87. PubMed ID: 14975305
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
    Imai S; Armstrong CM; Kaeberlein M; Guarente L
    Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule regulation of Sir2 protein deacetylases.
    Grubisha O; Smith BC; Denu JM
    FEBS J; 2005 Sep; 272(18):4607-16. PubMed ID: 16156783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
    Smith BC; Denu JM
    Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-step, nonenzymatic synthesis of O-acetyl-ADP-ribose and analogues from NAD and carboxylates.
    Szczepankiewicz BG; Koppetsch KJ; Perni RB
    J Org Chem; 2011 Aug; 76(16):6465-74. PubMed ID: 21639110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions.
    Sauve AA; Celic I; Avalos J; Deng H; Boeke JD; Schramm VL
    Biochemistry; 2001 Dec; 40(51):15456-63. PubMed ID: 11747420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.
    Tanner KG; Landry J; Sternglanz R; Denu JM
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14178-82. PubMed ID: 11106374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the sirtuin mechanism from ternary complexes containing NAD+ and acetylated peptide.
    Hoff KG; Avalos JL; Sens K; Wolberger C
    Structure; 2006 Aug; 14(8):1231-40. PubMed ID: 16905097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.
    Frye RA
    Biochem Biophys Res Commun; 1999 Jun; 260(1):273-9. PubMed ID: 10381378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity in the Sir2 family of protein deacetylases.
    Buck SW; Gallo CM; Smith JS
    J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation.
    Liou GG; Tanny JC; Kruger RG; Walz T; Moazed D
    Cell; 2005 May; 121(4):515-527. PubMed ID: 15907466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.